bullish
Indegene Limited (1864095D IN) Pre-IPO: Enough Head Room For Long-Term Profitable Growth
Tina has highlighted this Insight as a Top Pick
532 Views13 Apr 2023 19:48
SUMMARY
- Indegene Limited (1864095D IN), a healthtech firm focused on life sciences commercialization is looking to raise INR32B through an IPO, comprises of fresh issue and an offer for sale.
- The IPO funds will be used to repay debt, fund capex, pay for one of the company’s past acquisitions, and pursue any future inorganic growth.
- Amid a large and growing underpenetrated addressable market, Indegene is poised for long-term profitable growth by leveraging on its marquee clientele, long-standing client relationship, and comprehensive offering.
Get started on the Smartkarma Research Network with a complimentary Preview Pass to:
- Unlock all research summaries
- Follow top, independent analysts
- Receive personalised alerts and emails
- Access Briefings, Analytics, and Events
Upgrade anytime to our paid plans for full-length research, real-time analyst discussions, and more.
Join a thriving community of 45,000+ investors, including the top global asset managers managing over $13trn in assets.
or
Already have an account? Sign In Now
Discussions
(Paid Plans Only)
Top Quartile
Tina Banerjee
Global Healthcare Analyst
Price Chart(Sign Up to Access)
- Indegene IPO - Marquee Clients, Strong Track Record, Decent Valuation03 May 2024
- Indegene Limited Pre-IPO: Subscribe on Profitable Niche Business Model and Attractive Valuation29 Apr 2024
- Indegene Limited (1864095D IN) Pre-IPO: Enough Head Room For Long-Term Profitable Growth13 Apr 2023
- Indegene Pre-IPO Tearsheet22 Dec 2022
x